Actively Recruiting

Phase Not Applicable
Age: 60Years - 85Years
All Genders
NCT06801639

Advancing Alzheimer's Care: Home-based tDCS for Affective Symptoms

Led by The University of Texas Health Science Center at San Antonio · Updated on 2026-02-11

24

Participants Needed

1

Research Sites

176 weeks

Total Duration

On this page

Sponsors

T

The University of Texas Health Science Center at San Antonio

Lead Sponsor

A

Alzheimer's Association

Collaborating Sponsor

AI-Summary

What this Trial Is About

Participants will be asked to participate in this research study of a device that creates transcranial direct current stimulation (tDCS). The researchers hope to learn if 30 minute sessions of transcranial direct current stimulation (tDCS) improve such a mood or feelings in people with Alzheimer's Disease. This study involves the use of an investigational device called a tDC stimulator. "Investigational" means that the device has not yet been approved by the U.S. Food \& Drug Administration (FDA) for treating Alzheimer's Disease. This study will help find out what effects, good and/or bad, this has. The safety of this device in humans has been tested in prior research studies; however, some side effects may not yet be known.

CONDITIONS

Official Title

Advancing Alzheimer's Care: Home-based tDCS for Affective Symptoms

Who Can Participate

Age: 60Years - 85Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Ability to understand and willingly sign informed consent
  • Age 60 years or older
  • Diagnosis of possible or probable Alzheimer's Disease or mild cognitive impairment due to Alzheimer's with supporting biomarker evidence
  • Clinical Dementia Rating of 0.5 (MCI) with biomarker evidence or 1-2 (mild to moderate dementia) as determined by the study physician
  • Presence of any affective symptom such as depression, anxiety, irritability, or apathy with a Neuropsychiatric Inventory Questionnaire total severity score of 10 or higher
  • Have an eligible caregiver willing to be present during stimulation sessions and assist with questionnaires
  • Ability to speak and read English
  • Stable medication doses for at least one month
  • Access to reliable broadband internet
  • Caregiver is an adult unpaid helper with adequate cognitive, reading, writing, hearing, and verbal skills to assist and provide collateral information
Not Eligible

You will not qualify if you...

  • Unstable medical conditions that could affect safety or data quality (e.g., unstable angina, uncontrolled diabetes or hypertension, advanced cancer)
  • History of serious psychiatric disorders such as bipolar disorder, schizophrenia, or manic depression
  • History of epilepsy
  • Presence of metallic objects in the brain or skull that interfere with stimulation
  • Risk of suicidal behavior or active suicidal ideation with intent or plan in the past 3 months
  • Unwillingness or medical contraindication preventing MRI scans at baseline and during week 2
  • Participation in other therapeutic clinical trials
  • Caregivers who do not meet all inclusion criteria

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Texas Health Science Center at San Antonio

San Antonio, Texas, United States, 78229

Actively Recruiting

Loading map...

Research Team

T

Thiago Macedo e Cordeiro, MD, MSc

CONTACT

A

Antonio L Teixeira, MD, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here